A study of the transformation of umbilical cord mesenchymal stem cells by interferon-gamma

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 194

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-9_006

تاریخ نمایه سازی: 24 شهریور 1400

چکیده مقاله:

Objective(s): Mesenchymal stem cells (MSCs) exist in almost all tissues. Their unique nature is completed by their immunomodulatory functions, holding promise for the treatment of many diseases. An inflammatory environment precedes the immunosuppressive abilities of MSCs and this study was intended to better understand how umbilical cord MSCs (UCMSCs) react to the process of inflammation, regarding their basic characteristics and behavior when primed with the key pro-inflammatory cytokine, Interferon-γ (IFNγ).Materials and Methods: Human MSCs from the umbilical cord were isolated, expanded, and treated with IFNγ. Primed cells were analyzed to define their ability to form colonies, their morphology, differentiation potential, proliferation, and apoptosis rate.  Results: UCMSCs treated with IFNγ changed their fibroblast-like morphology and retained the expression of typical MSCs markers. IFNγ treated UCMSCs had significantly higher MFI levels regarding the expression of HLA-I (۹۸۰.۴۳ ± ۵۵۶.۶۴) and PD-L۱ (۵۹۸.۰۴ ± ۴۱۶.۹۰) compared with the control cells (۱۴۴.۹۷ ± ۷۸.۵ and ۱۲۲.۰۵ ± ۱۰۳.۸۳, respectively; p <۰.۰۱). Under the influence of IFNγ, the cells had a lower population doubling time compared with the control cultures (۵۰.۳۴۵ ± ۹.۱۵۵ versus ۶۱.۱۳۵ ± ۲۱.۱۱۰, respectively; p <۰.۰۱) and higher numbers of colony-forming unit-fibroblasts (۲۶.۰ ± ۱۲.۲ versus ۱۰.۲ ± ۸.۰, respectively; p <۰.۰۵). The primed MSCs could not undergo osteogenic and adipogenic differentiation. IFNγ increased the percentage of cells in the apoptotic state on day eight (۲۹.۴۷۰ ± ۶.۵۹ versus ۱۵.۷۰۸ ± ۶.۱۹۰, respectively; p <۰.۰۱).Conclusion: The properties of UCMSCs can be influenced by the pro-inflammatory cytokine IFNγ.

نویسندگان

Kalina Belemezova

Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Department of Clinical Immunology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria, Ob/Gyn Hospital Dr Shterev, Sofia, Bulgaria

Ivan Bochev

Department of Molecular Immunology, Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, Sofia, Bulgaria, Ob/Gyn Hospital Dr Shterev, Sofia, Bulgaria

Ekaterina Ivanova-Todorova

Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Department of Clinical Immunology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria

Stanimir Kyurkchiev

Ob/Gyn Hospital Dr Shterev, Sofia, Bulgaria

Dobroslav Kyurkchiev

Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Department of Clinical Immunology, Medical Faculty, Medical University of Sofia, Sofia, Bulgaria

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hass R, Kasper C, Böhm S, Jacobs R. Different populations ...
  • Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: ...
  • Dominici ML, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini ...
  • Saeedi P, Halabian R, Fooladi AA. A revealing review of ...
  • Raza SS, Seth P, Khan MA. ‘Primed’mesenchymal stem cells: A ...
  • Patel DM, Shah J, Srivastava AS. Therapeutic potential of mesenchymal ...
  • Ben-Ami E, Berrih-Aknin S, Miller A. Mesenchymal stem cells as ...
  • Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HL. ...
  • Liang C, Jiang E, Yao J, Wang M, Chen S, ...
  • Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, ...
  • Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon‐γ does ...
  • Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L. ...
  • Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, ...
  • Prasanna JS, Gopalakrishnan D, Shankar SR, Vasandan AB. Pro-inflammatory cytokines, ...
  • Chan WK, Lau AS, Li JC, Law HK, Lau YL, ...
  • Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, ...
  • Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. ...
  • Logue SE, Elgendy M, Martin SJ. Expression, purification and use ...
  • Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, ...
  • Bach EA, Aguet M, Schreiber RD. The IFNγ receptor: A ...
  • Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori MS, ...
  • Croitoru-Lamoury J, Lamoury FM, Caristo M, Suzuki K, Walker D, ...
  • Strojny C, Boyle M, Bartholomew A, Sundivakkam P, Alapati S. ...
  • Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, ...
  • Svensson-Arvelund J, Ernerudh J, Buse E, Cline JM, Haeger JD, ...
  • Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, ...
  • Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, ...
  • Augello A, Tasso R, Negrini SM, Amateis A, Indiveri F, ...
  • Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, ...
  • Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, ...
  • Garcia-Diaz A, Shin DS, Moreno BH, Saco J, Escuin-Ordinas H, ...
  • Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, ...
  • Strauch V, Saul D, Berisha M, Mackensen A, Mougiakakos D, ...
  • Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, ...
  • Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, ...
  • Chan J, O’Donoghue K, de la Fuente J, Roberts IA, ...
  • Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, ...
  • Du J, Zhou L, Chen X, Yan S, Ke M, ...
  • Duijvestein M, Wildenberg ME, Welling MM, Hennink S, Molendijk I, ...
  • Kim DS, Jang IK, Lee MW, Ko YJ, Lee DH, ...
  • نمایش کامل مراجع